EARNINGS FORECAST: Roche's core earnings per share are expected to come in at 18.59 francs, according to the Visible Alpha consensus. For 2023, the company reported core EPS of 18.57 francs. As of ...
To receive daily news and insights, subscribe to our free daily BioPharma Dive newsletter. Roche has a big problem. With competition threatening some of its older and most lucrative biologic drugs, ...